New developments in vaginal contraception.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000293:Adolescent; D000328:Adult; D001291:Attitude of Health Personnel; D003267:Contraception / Q000379:methods* / Q000639:trends; D003274:Contraceptive Devices, Female / Q000009:adverse effects / Q000592:standards / Q000600:supply & distribution; D003906:Developing Countries; D005193:Family Planning Services; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008389:Marketing of Health Services; D008875:Middle Aged; D017137:Nonoxynol; D000292:Pelvic Inflammatory Disease / Q000517:prevention & control; D011092:Polyethylene Glycols / Q000008:administration & dosage; D011247:Pregnancy; D012749:Sexually Transmitted Diseases / Q000517:prevention & control; D012772:Shock, Septic / Q000209:etiology / Q000517:prevention & control; D013089:Spermatocidal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000600:supply & distribution; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control; D014622:Vaginal Creams, Foams, and Jellies / Q000008:administration & dosage* / Q000009:adverse effects / Q000600:supply & distribution
D013089:Spermatocidal Agents; D014622:Vaginal Creams, Foams, and Jellies; D017137:Nonoxynol; D011092:Polyethylene Glycols